Altria Group had mixed Q1'25 earnings. Click here to read why I continue to see MO stock as an investment worth holding.

June 21 (UPI) --The U.S. Food and Drug Administration on Friday cleared four NJOY menthol-flavored e-cigarette products to be marketed in the United States. The FDA in a statement said it issued ...

However, its efforts to transition revenues away from tobacco have been fraught, with the latest setback being a block on the imports of its NJOY ACE vapes as part of a patent dispute with e ...

Altria told investors Tuesday that while it is monitoring the impact of President Donald Trump’s tariffs, it’s still expecting profits this year will rise.

The Food and Drug Administration (FDA), which until Friday had approved only tobacco-flavored nicotine vaping products, has now officially allowed the sale of menthol-flavored NJOY Daily ...

(Reuters) -Tobacco company Altria on Tuesday beat first-quarter profit estimates but flagged an $873 million impairment at its e-cigarette business, where shipments dropped 70% amid a patent dispute.